An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure

समान संसाधन

• Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
  द्वारा: Cortes, Jorge E., और अन्य
  प्रकाशित: (2018)
• Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies
  द्वारा: Ruiz‐Garcia, Ana, और अन्य
  प्रकाशित: (2020)
• Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors
  द्वारा: Lin, Swan, और अन्य
  प्रकाशित: (2019)
• Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
  द्वारा: Cortes, Jorge E., और अन्य
  प्रकाशित: (2020)
• Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
  द्वारा: Quintás-Cardama, Alfonso, और अन्य
  प्रकाशित: (2012)